Cancer is a disease of uncontrolled cell growth. Cancer cells grow abnormally because of damage to their DNA. This DNA damage garbles the genetic signals for normal growth. The molecular approach to cancer gets to the heart of the matter. Molecular studies have uncovered many of the details whereby a normal cell becomes cancerous. These discoveries have revealed cancer to be a-multistep process, involving the progressive loss of control by the malignant cell, failure of DNA repair, and of loss of backup systems for preventing abnormal cell growth. We have discovered oncogenes, which promote tumor growth, as well as anti-oncogenes, which suppress tumors.


Chronic Myeloid Leukemia Human Papilloma Virus Gene Rearrangement Chromosomal Translocation Chronic Myeloid Leukemia Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ayscue LH, Ross DW, Ozer H, Rao K, Gulley ML, Dent GA (1990) Bcr/abl recombinant DNA analysis versus karyotype in the diagnosis and therapeutic monitoring of chronic myeloid leukemia. Am J Clin Pathol 94: 404–409.PubMedGoogle Scholar
  2. Burkitt D, O’Conor GT (1961) Malignant lymphoma in African children I. A clinical syndrome. Cancer 14: 258–269.Google Scholar
  3. Cossman J (ed) (1990) Molecular Genetics in Cancer Diagnosis. Elsevier, New York.Google Scholar
  4. Cossman J, Zehnbauer B, Garrett CT, Smith LJ, Williams M, Jaffe ES, Hanson LO, Love J (1991) Gene rearrangements in the diagnosis of lymphoma/ leukemia. Am J Clin Pathol 95: 347–354.PubMedGoogle Scholar
  5. Daley GQ, van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 247: 824–830.PubMedCrossRefGoogle Scholar
  6. de The H, Chomienne C, Lanotte M, Degos L, Dejean A (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558–561.PubMedCrossRefGoogle Scholar
  7. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 6 (61): 759–767.CrossRefGoogle Scholar
  8. Gulley ML, Dent GA, Ross DW (1992) Classification and staging of lymphoma by molecular genetics. Cancer (in press).Google Scholar
  9. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G (1985) Structural organization of the bcr gene and its role in the Ph’ translocation. Nature 315: 758–761.PubMedCrossRefGoogle Scholar
  10. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bd-2 is an inner mitochondrial membrance protein that blocks programmed cell death. Nature 348: 334–336.PubMedCrossRefGoogle Scholar
  11. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49–53.Google Scholar
  12. Hollingsworth RE, Lee WH (1991) Timor suppressor genes: New prospects for cancer research. JNCI 83: 82–96.Google Scholar
  13. Huang ME, Ye YI, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567–571.PubMedGoogle Scholar
  14. Jacquemier J, Penault F, Durst M, Parc P, Seradour B, Meynard P, Halfon P, Hassoun J (1990) Detection of five different human papillomavirus types in cervical lesions by in situ hybridization. Hum Pathol 21: 911–917.PubMedCrossRefGoogle Scholar
  15. Kern SE, Fearon ER, Tersmettee KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B, Hamilton S (1989) Allelic loss in colorectal carcinoma. JAMA 261 (21): 3099–3103.PubMedCrossRefGoogle Scholar
  16. Longo L, Pandolfi PP, Biondi A, Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Pegoraro L, Avanzi G, Tàbilio A, Zangrilli D, Alcalay M, Donti E, Grignani F, Pelicci PG (1990) Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J Exp Med 172: 1571–1575.PubMedCrossRefGoogle Scholar
  17. Lyons J, private communication; see also Lyons J, Landis CA, Harsh G, et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249: 655–659.PubMedCrossRefGoogle Scholar
  18. McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254–256.PubMedCrossRefGoogle Scholar
  19. Ross DW (1990) p53—A candidate antioncogene. Arch Pathol Lab Med 114:432.Google Scholar
  20. Slamon DJ, Godolphin W, Jones LA, et al. (1989) Studies of the HER-2/neu Proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.PubMedCrossRefGoogle Scholar
  21. Stanbridge EJ, Nowell PC (1990) Origins of human cancer revisited. Cell 63: 867–874.PubMedCrossRefGoogle Scholar
  22. zur Hausen H (1987) Papillomaviruses in human cancer. Cancer 59: 1692–1696.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Dennis W. Ross
    • 1
    • 2
  1. 1.The School of Medicine, Department of PathologyThe University of North Carolina at Chapel HillChapel HillUSA
  2. 2.Department of PathologyForsyth Memorial HospitalWinston-SalemUSA

Personalised recommendations